Cochlear Limited (CHEOF)
USD 165.34
(4.28%)
USD 165.34
(4.28%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 904.6 Million AUD | 10.33% |
| 2023 | 819.9 Million AUD | 5.2% |
| 2022 | 779.4 Million AUD | 5.82% |
| 2021 | 736.5 Million AUD | -37.28% |
| 2020 | 1.17 Billion AUD | 79.73% |
| 2019 | 653.3 Million AUD | 19.63% |
| 2018 | 546.1 Million AUD | -7.86% |
| 2017 | 592.71 Million AUD | 16.49% |
| 2016 | 508.8 Million AUD | -0.95% |
| 2015 | 513.67 Million AUD | 11.71% |
| 2014 | 459.83 Million AUD | 12.82% |
| 2013 | 407.58 Million AUD | 28.31% |
| 2012 | 317.66 Million AUD | 33.6% |
| 2011 | 237.76 Million AUD | -24.14% |
| 2010 | 313.41 Million AUD | -0.55% |
| 2009 | 315.13 Million AUD | 9.21% |
| 2008 | 288.57 Million AUD | -11.19% |
| 2007 | 324.92 Million AUD | -3.34% |
| 2006 | 336.14 Million AUD | -1.1% |
| 2005 | 339.87 Million AUD | 185.59% |
| 2004 | 119.01 Million AUD | 7.32% |
| 2003 | 110.89 Million AUD | 30.44% |
| 2002 | 85.01 Million AUD | 15.58% |
| 2001 | 73.55 Million AUD | 44.39% |
| 2000 | 50.94 Million AUD | 4.2% |
| 1999 | 48.88 Million AUD | 32.07% |
| 1998 | 37.01 Million AUD | 32.3% |
| 1997 | 27.98 Million AUD | -6.06% |
| 1996 | 29.78 Million AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q4 | 904.6 Million AUD | 20.82% |
| 2024 FY | 904.6 Million AUD | 10.33% |
| 2024 Q2 | 748.7 Million AUD | -8.68% |
| 2023 FY | 819.9 Million AUD | 5.2% |
| 2023 Q4 | 819.9 Million AUD | 9.12% |
| 2023 Q2 | 751.4 Million AUD | -3.59% |
| 2022 Q4 | 779.4 Million AUD | 10.99% |
| 2022 Q2 | 702.2 Million AUD | -4.66% |
| 2022 FY | 779.4 Million AUD | 5.82% |
| 2021 FY | 736.5 Million AUD | -37.28% |
| 2021 Q4 | 736.5 Million AUD | 2.43% |
| 2021 Q2 | 719 Million AUD | -38.77% |
| 2020 Q2 | 836.9 Million AUD | 28.1% |
| 2020 FY | 1.17 Billion AUD | 79.73% |
| 2020 Q4 | 1.17 Billion AUD | 40.3% |
| 2019 Q2 | 595.4 Million AUD | 9.03% |
| 2019 Q4 | 653.3 Million AUD | 9.72% |
| 2019 FY | 653.3 Million AUD | 19.63% |
| 2018 FY | 546.1 Million AUD | -7.86% |
| 2018 Q4 | 546.1 Million AUD | -10.42% |
| 2018 Q2 | 609.6 Million AUD | 2.85% |
| 2017 Q4 | 592.71 Million AUD | 19.5% |
| 2017 Q2 | 495.97 Million AUD | -2.52% |
| 2017 FY | 592.71 Million AUD | 16.49% |
| 2016 Q2 | 508.79 Million AUD | -0.95% |
| 2016 FY | 508.8 Million AUD | -0.95% |
| 2016 Q4 | 508.8 Million AUD | 0.0% |
| 2015 Q4 | 513.67 Million AUD | 1.45% |
| 2015 FY | 513.67 Million AUD | 11.71% |
| 2015 Q2 | 506.31 Million AUD | 10.11% |
| 2014 Q4 | 459.83 Million AUD | -6.01% |
| 2014 FY | 459.83 Million AUD | 12.82% |
| 2014 Q2 | 489.25 Million AUD | 20.04% |
| 2013 Q4 | 407.58 Million AUD | 0.0% |
| 2013 FY | 407.58 Million AUD | 28.31% |
| 2012 FY | 317.66 Million AUD | 33.6% |
| 2012 Q4 | 317.66 Million AUD | 0.0% |
| 2011 Q4 | 237.76 Million AUD | 0.0% |
| 2011 FY | 237.76 Million AUD | -24.14% |
| 2010 Q4 | 313.41 Million AUD | 0.0% |
| 2010 FY | 313.41 Million AUD | -0.55% |
| 2009 Q4 | 315.13 Million AUD | 0.0% |
| 2009 FY | 315.13 Million AUD | 9.21% |
| 2008 FY | 288.57 Million AUD | -11.19% |
| 2008 Q4 | 288.57 Million AUD | 0.0% |
| 2007 FY | 324.92 Million AUD | -3.34% |
| 2007 Q4 | 324.92 Million AUD | 0.0% |
| 2006 Q4 | 336.14 Million AUD | 0.0% |
| 2006 FY | 336.14 Million AUD | -1.1% |
| 2005 FY | 339.87 Million AUD | 185.59% |
| 2005 Q4 | 339.87 Million AUD | 0.0% |
| 2004 Q4 | 119.01 Million AUD | 0.0% |
| 2004 FY | 119.01 Million AUD | 7.32% |
| 2003 Q4 | 110.89 Million AUD | 0.0% |
| 2003 FY | 110.89 Million AUD | 30.44% |
| 2002 FY | 85.01 Million AUD | 15.58% |
| 2002 Q4 | 85.01 Million AUD | 0.0% |
| 2001 Q4 | 73.55 Million AUD | 0.0% |
| 2001 FY | 73.55 Million AUD | 44.39% |
| 2000 FY | 50.94 Million AUD | 4.2% |
| 2000 Q4 | 50.94 Million AUD | 0.0% |
| 1999 FY | 48.88 Million AUD | 32.07% |
| 1999 Q4 | 48.88 Million AUD | 0.0% |
| 1998 Q4 | 37.01 Million AUD | 0.0% |
| 1998 FY | 37.01 Million AUD | 32.3% |
| 1997 FY | 27.98 Million AUD | -6.06% |
| 1997 Q4 | 27.98 Million AUD | 0.0% |
| 1996 FY | 29.78 Million AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| IR-Med Inc. | 634 Thousand USD | -142581.388% |
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 16.62 Million USD | -5341.921% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | -133397.438% |
| Polarean Imaging plc | 2.58 Million USD | -34954.692% |
| Avitar, Inc. | 11.59 Million USD | -7702.624% |
| AVITA Medical, Inc. | 19.86 Million USD | -4453.645% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | -42610.104% |
| Össur hf. | 688.8 Million USD | -31.329% |
| Zecotek Photonics Inc. | 5.86 Million USD | -15314.223% |
| QHSLab, Inc. | 2.05 Million USD | -43875.617% |
| Wellstar International, Inc. | 55.99 Million USD | -1515.63% |
| Össur hf. | 688.8 Million USD | -31.329% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | -5525.435% |
| Escalon Medical Corp. | 2.94 Million USD | -30581.641% |
| Aurora Spine Corporation | 6.65 Million USD | -13495.778% |
| BrainsWay Ltd. | 15.31 Million USD | -5807.013% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 6.01 Million USD | -14944.954% |
| Hamilton Thorne Ltd. | 45.84 Million USD | -1873.264% |
| Vivos Inc. | 245 Thousand USD | -369118.462% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 63.618% |
| Kelyniam Global, Inc. | 1.01 Million USD | -89204.842% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -328112.645% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | -36825.343% |
| Nanomix Corporation | 14.81 Million USD | -6006.078% |
| Theraclion SA | 13.01 Million EUR | -6849.604% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 5.12 Million USD | -17553.498% |
| Positron Corporation | 2.02 Million USD | -44549.6% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | -24880.876% |
| Lombard Medical, Inc. | 53.79 Million USD | -1581.6% |
| ALR Technologies Inc. | 24.5 Million USD | -3591.437% |
| Stratec SE | 271.97 Million USD | -232.61% |
| Vycor Medical, Inc. | 4.31 Million USD | -20850.61% |
| Heart Tronics, Inc. | 1.09 Million USD | -82527.794% |
| Nu-Med Plus, Inc. | 2.35 Million USD | -38250.236% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | -16417.65% |
| SANUWAVE Health, Inc. | 65.59 Million USD | -1279.09% |
| VMS Rehab Systems, Inc. | 201.36 USD | -449245033.095% |
| Guided Therapeutics, Inc. | 5.47 Million USD | -16422.374% |
| Ingen Technologies, Inc. | 5.7 Million USD | -15743.639% |
| Odyssey Group International, Inc. | 6.61 Million USD | -13581.761% |
| United American Healthcare Corporation | 119 Thousand USD | -760068.067% |
| ECGI Holdings, Inc. | 11.94 Million USD | -7475.985% |
| Capital Group Holdings, Inc. | 1.32 Million USD | -68224.089% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | -62444.207% |
| Urologix, Inc. | 12.64 Million USD | -7054.382% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | -16664.074% |
| Nexeon MedSystems Inc. | 8.48 Million USD | -10564.365% |
| SS Innovations International, Inc. | 11.18 Million USD | -7990.437% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | -172077.842% |
| Smith & Nephew plc | 4.76 Billion USD | 81.009% |
| NIOX Group Plc | 9.8 Million USD | -9128.635% |
| Fuse Medical, Inc. | 15.11 Million USD | -5886.738% |
| Broncus Holding Corporation | 10.43 Million USD | -8571.256% |
| Brain Scientific Inc. | 7.42 Million USD | -12080.863% |
| Pressure BioSciences, Inc. | 33.8 Million USD | -2576.054% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | -113817.85% |